Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
GeoVax Labs receives notice of allowance for Hepatitis B vaccine patent » 09:03
04/01/21
04/01
09:03
04/01/21
09:03
GOVX

GeoVax Labs

$4.37 /

+0.19 (+4.55%)

GeoVax Labs announced…

GeoVax Labs announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent Application No. 16/305,305 entitled "Composition and Methods of Generating an Immune Response to Hepatitis B Virus." The work supporting the patent application was performed through a collaboration between GeoVax and Georgia State University and the patent is jointly owned by the company and the Georgia State University Research Foundation. David Dodd, GeoVax's Chairman & CEO, commented, "While our corporate focus and development priorities continue to be our COVID-19 vaccine and cancer immunotherapy programs, developing a treatment for chronic Hepatitis B infections is also of interest and under consideration as part of our longer-term focus. This patent allowance adds to our growing portfolio of wholly owned, co-owned, and in-licensed intellectual property, which now stands at over 70 granted or pending patent applications spread over 20 patent families."

ShowHide Related Items >><<
GOVX GeoVax Labs
$4.37 /

+0.19 (+4.55%)

GOVX GeoVax Labs
$4.37 /

+0.19 (+4.55%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
  • 25
    Sep
GOVX GeoVax Labs
$4.37 /

+0.19 (+4.55%)

Conference/Events
Benzinga to hold a virtual conference » 04:55
03/25/21
03/25
04:55
03/25/21
04:55
ACRX

AcelRx

$1.66 /

-0.105 (-5.97%)

, ADTX

Aditx Therapeutics

$2.78 /

-0.38 (-12.03%)

, ALIM

Alimera Sciences

$9.67 /

-0.04 (-0.41%)

, AMYT

Amryt Pharma

$13.00 /

-0.61 (-4.48%)

, ATNM

Actinium Pharmaceuticals

$8.28 /

-0.19 (-2.24%)

, AXLA

Axcella Health

$4.55 /

-0.38 (-7.71%)

, BSGM

BioSig Technologies

$4.30 /

-0.14 (-3.15%)

, CLVR

Clever Leaves

$12.31 /

-0.4 (-3.15%)

, DXR

Daxor

$11.56 /

-1.28 (-9.97%)

, ENVB

Enveric Biosciences

$3.44 /

+0.1 (+2.99%)

, GLSI

Greenwich LifeSciences

$31.95 /

+1.46 (+4.79%)

, GOVX

GeoVax Labs

$4.85 /

-0.05 (-1.02%)

, HEPA

Hepion Pharmaceuticals

$1.92 /

-0.235 (-10.90%)

, HOTH

Hoth Therapeutics

$2.21 /

-0.31 (-12.30%)

, KRBP

Kiromic BioPharma

$9.56 /

-0.24 (-2.45%)

, KTRA

Kintara Therapeutics

$1.88 /

-0.085 (-4.33%)

, LIFE

aTyr Pharma

$4.66 /

-0.27 (-5.48%)

, SRNE

Sorrento Therapeutics

$8.45 /

-0.73 (-7.95%)

, SKYE

Skye Bioscience

$0.00 /

+ (+0.00%)

, QLGN

Qualigen Therapeutics

$2.63 /

-0.23 (-8.04%)

, PRPH

ProPhase Labs

$6.78 /

+0.08 (+1.19%)

, YTEN

Yield10 Bioscience

$13.57 /

-0.66 (-4.64%)

, ONCS

OncoSec

$5.29 /

-0.21 (-3.82%)

, NMTC

Numerical Technologies

$0.00 /

+ (+0.00%)

Benzinga Biotech Small…

Benzinga Biotech Small Cap Virtual Conference will be held on March 24-25. Webcast Link

ShowHide Related Items >><<
YTEN Yield10 Bioscience
$13.57 /

-0.66 (-4.64%)

SRNE Sorrento Therapeutics
$8.45 /

-0.73 (-7.95%)

SKYE Skye Bioscience
$0.00 /

+ (+0.00%)

QLGN Qualigen Therapeutics
$2.63 /

-0.23 (-8.04%)

PRPH ProPhase Labs
$6.78 /

+0.08 (+1.19%)

ONCS OncoSec
$5.29 /

-0.21 (-3.82%)

LIFE aTyr Pharma
$4.66 /

-0.27 (-5.48%)

KTRA Kintara Therapeutics
$1.88 /

-0.085 (-4.33%)

KRBP Kiromic BioPharma
$9.56 /

-0.24 (-2.45%)

HOTH Hoth Therapeutics
$2.21 /

-0.31 (-12.30%)

HEPA Hepion Pharmaceuticals
$1.92 /

-0.235 (-10.90%)

GOVX GeoVax Labs
$4.85 /

-0.05 (-1.02%)

GLSI Greenwich LifeSciences
$31.95 /

+1.46 (+4.79%)

ENVB Enveric Biosciences
$3.44 /

+0.1 (+2.99%)

DXR Daxor
$11.56 /

-1.28 (-9.97%)

CLVR Clever Leaves
$12.31 /

-0.4 (-3.15%)

BSGM BioSig Technologies
$4.30 /

-0.14 (-3.15%)

AXLA Axcella Health
$4.55 /

-0.38 (-7.71%)

ATNM Actinium Pharmaceuticals
$8.28 /

-0.19 (-2.24%)

AMYT Amryt Pharma
$13.00 /

-0.61 (-4.48%)

ALIM Alimera Sciences
$9.67 /

-0.04 (-0.41%)

ADTX Aditx Therapeutics
$2.78 /

-0.38 (-12.03%)

ACRX AcelRx
$1.66 /

-0.105 (-5.97%)

ACRX AcelRx
$1.66 /

-0.105 (-5.97%)

02/17/21 H.C. Wainwright
AcelRx warning letter is a 'nothingburger,' says H.C. Wainwright
07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
07/20/20
Fly Intel: Top five analyst downgrades
07/20/20 Credit Suisse
AcelRx downgraded to Underperform on 'mounting challenges' at Credit Suisse
ADTX Aditx Therapeutics
$2.78 /

-0.38 (-12.03%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Dawson James
Aditx Therapeutics initiated with a Buy at Dawson James
ALIM Alimera Sciences
$9.67 /

-0.04 (-0.41%)

02/26/21 Alliance Global Partners
Alimera Sciences price target raised to $15 from $12 at Alliance Global Partners
01/07/21 Alliance Global Partners
Iluvien deal shows valuation disconnect at Alimera, says Alliance Global Partners
04/07/20 B. Riley
Alimera Sciences price target lowered to $15 from $24 at B. Riley FBR
AMYT Amryt Pharma
$13.00 /

-0.61 (-4.48%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
ATNM Actinium Pharmaceuticals
$8.28 /

-0.19 (-2.24%)

12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
11/05/20 Alliance Global Partners
Actinium Pharmaceuticals initiated with a Buy at Alliance Global Partners
AXLA Axcella Health
$4.55 /

-0.38 (-7.71%)

03/22/21 Wedbush
Axcella Health price target lowered to $11 from $19 at Wedbush
03/18/21 Chardan
Axcella Health moving forward with two lead programs, says Chardan
11/18/20 Roth Capital
Axcella Health initiated with a Buy at Roth Capital
10/27/20
Fly Intel: Top five analyst initiations
BSGM BioSig Technologies
$4.30 /

-0.14 (-3.15%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Roth Capital
BioSig Technologies initiated with a Buy at Roth Capital
CLVR Clever Leaves
$12.31 /

-0.4 (-3.15%)

DXR Daxor
$11.56 /

-1.28 (-9.97%)

ENVB Enveric Biosciences
$3.44 /

+0.1 (+2.99%)

GLSI Greenwich LifeSciences
$31.95 /

+1.46 (+4.79%)

GOVX GeoVax Labs
$4.85 /

-0.05 (-1.02%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
HEPA Hepion Pharmaceuticals
$1.92 /

-0.235 (-10.90%)

12/01/20 Roth Capital
Hepion Pharmaceuticals price target lowered to $8 from $14 at Roth Capital
07/20/20 Roth Capital
Hepion Pharmaceuticals transferred with a Buy rating at Roth Capital
HOTH Hoth Therapeutics
$2.21 /

-0.31 (-12.30%)

KRBP Kiromic BioPharma
$9.56 /

-0.24 (-2.45%)

KTRA Kintara Therapeutics
$1.88 /

-0.085 (-4.33%)

09/14/20 Aegis
Kintara Therapeutics initiated with a Buy at Aegis
LIFE aTyr Pharma
$4.66 /

-0.27 (-5.48%)

03/16/21 Roth Capital
aTyr Pharma price target raised to $20 from $15 at Roth Capital
01/28/21 Roth Capital
Roth Capital says aTyr Pharma work on NRP2 'not to be ignored'
01/05/21 Roth Capital
Roth sees aTyr '1923 data 'supportive' of anti-inflammatory potential in COVID
08/17/20 H.C. Wainwright
aTyr Pharma upgraded to Buy from Neutral at H.C. Wainwright
SRNE Sorrento Therapeutics
$8.45 /

-0.73 (-7.95%)

01/29/21 B. Riley
Sorrento Therapeutics initiated with a Buy at B. Riley Securities
01/21/21 Alliance Global Partners
Sorrento Therapeutics initiated with a Buy at Alliance Global Partners
07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
SKYE Skye Bioscience
$0.00 /

+ (+0.00%)

QLGN Qualigen Therapeutics
$2.63 /

-0.23 (-8.04%)

08/25/20 Alliance Global Partners
Qualigen upgraded to Buy from Neutral at Alliance Global Partners
PRPH ProPhase Labs
$6.78 /

+0.08 (+1.19%)

01/20/21 Dawson James
ProPhase Labs initiated with a Buy at Dawson James
YTEN Yield10 Bioscience
$13.57 /

-0.66 (-4.64%)

02/10/21 Maxim
Yield10 Bioscience price target raised to $24 from $12 at Maxim
02/09/21 Maxim
Yield10 Bioscience price target raised to $24 from $12 at Maxim
01/19/21 H.C. Wainwright
Yield10 Bioscience proof-of-concept validates pipeline, says H.C. Wainwright
09/10/20 H.C. Wainwright
Yield10 Bioscience initiated with a Buy at H.C. Wainwright
ONCS OncoSec
$5.29 /

-0.21 (-3.82%)

03/08/21
Fly Intel: Top five analyst initiations
03/08/21 BTIG
OncoSec initiated with a Buy at BTIG
07/27/20 Dawson James
OncoSec initiated with a Buy at Dawson James
07/14/20 Alliance Global Partners
OncoSec price target lowered to $6.50 from $9 at Alliance Global Partners
NMTC Numerical Technologies
$0.00 /

+ (+0.00%)

YTEN Yield10 Bioscience
$13.57 /

-0.66 (-4.64%)

QLGN Qualigen Therapeutics
$2.63 /

-0.23 (-8.04%)

LIFE aTyr Pharma
$4.66 /

-0.27 (-5.48%)

KTRA Kintara Therapeutics
$1.88 /

-0.085 (-4.33%)

AXLA Axcella Health
$4.55 /

-0.38 (-7.71%)

ALIM Alimera Sciences
$9.67 /

-0.04 (-0.41%)

ADTX Aditx Therapeutics
$2.78 /

-0.38 (-12.03%)

ACRX AcelRx
$1.66 /

-0.105 (-5.97%)

  • 16
    Feb
  • 01
    Feb
  • 21
    Jan
  • 20
    Jan
  • 18
    Dec
  • 25
    Nov
  • 16
    Oct
  • 25
    Sep
  • 25
    Sep
  • 30
    Jun
  • 17
    Jun
  • 22
    May
  • 14
    May
  • 22
    Apr
GLSI Greenwich LifeSciences
$31.95 /

+1.46 (+4.79%)

YTEN Yield10 Bioscience
$13.57 /

-0.66 (-4.64%)

SRNE Sorrento Therapeutics
$8.45 /

-0.73 (-7.95%)

SKYE Skye Bioscience
$0.00 /

+ (+0.00%)

PRPH ProPhase Labs
$6.78 /

+0.08 (+1.19%)

ONCS OncoSec
$5.29 /

-0.21 (-3.82%)

LIFE aTyr Pharma
$4.66 /

-0.27 (-5.48%)

KRBP Kiromic BioPharma
$9.56 /

-0.24 (-2.45%)

GOVX GeoVax Labs
$4.85 /

-0.05 (-1.02%)

GLSI Greenwich LifeSciences
$31.95 /

+1.46 (+4.79%)

ENVB Enveric Biosciences
$3.44 /

+0.1 (+2.99%)

CLVR Clever Leaves
$12.31 /

-0.4 (-3.15%)

AXLA Axcella Health
$4.55 /

-0.38 (-7.71%)

ATNM Actinium Pharmaceuticals
$8.28 /

-0.19 (-2.24%)

ACRX AcelRx
$1.66 /

-0.105 (-5.97%)

SRNE Sorrento Therapeutics
$8.45 /

-0.73 (-7.95%)

QLGN Qualigen Therapeutics
$2.63 /

-0.23 (-8.04%)

PRPH ProPhase Labs
$6.78 /

+0.08 (+1.19%)

ONCS OncoSec
$5.29 /

-0.21 (-3.82%)

HEPA Hepion Pharmaceuticals
$1.92 /

-0.235 (-10.90%)

CLVR Clever Leaves
$12.31 /

-0.4 (-3.15%)

BSGM BioSig Technologies
$4.30 /

-0.14 (-3.15%)

ADTX Aditx Therapeutics
$2.78 /

-0.38 (-12.03%)

ACRX AcelRx
$1.66 /

-0.105 (-5.97%)

Conference/Events
Benzinga to hold a virtual conference » 10:00
03/24/21
03/24
10:00
03/24/21
10:00
ACRX

AcelRx

$1.70 /

-0.06 (-3.41%)

, ADTX

Aditx Therapeutics

$3.17 /

+0.01 (+0.32%)

, ALIM

Alimera Sciences

$9.71 /

+ (+0.00%)

, AMYT

Amryt Pharma

$13.61 /

+ (+0.00%)

, ATNM

Actinium Pharmaceuticals

$8.78 /

+0.31 (+3.66%)

, AXLA

Axcella Health

$4.90 /

-0.03 (-0.61%)

, BSGM

BioSig Technologies

$4.53 /

+0.09 (+2.03%)

, CLVR

Clever Leaves

$12.60 /

-0.11 (-0.87%)

, DXR

Daxor

$12.29 /

-0.55 (-4.28%)

, ENVB

Enveric Biosciences

$3.33 /

-0.01 (-0.30%)

, GLSI

Greenwich LifeSciences

$32.27 /

+1.78 (+5.84%)

, GOVX

GeoVax Labs

$4.96 /

+0.06 (+1.22%)

, HEPA

Hepion Pharmaceuticals

$2.08 /

-0.075 (-3.48%)

, HOTH

Hoth Therapeutics

$2.30 /

-0.22 (-8.73%)

, KRBP

Kiromic BioPharma

$9.60 /

-0.2 (-2.04%)

, KTRA

Kintara Therapeutics

$1.98 /

+0.015 (+0.76%)

, LIFE

aTyr Pharma

$5.30 /

+0.37 (+7.51%)

, SRNE

Sorrento Therapeutics

$8.96 /

-0.22 (-2.40%)

, SKYE

Skye Bioscience

$0.00 /

+ (+0.00%)

, QLGN

Qualigen Therapeutics

$2.93 /

+0.07 (+2.45%)

, PRPH

ProPhase Labs

$6.70 /

+ (+0.00%)

, YTEN

Yield10 Bioscience

$14.20 /

-0.03 (-0.21%)

, ONCS

OncoSec

$5.46 /

-0.04 (-0.73%)

, NMTC

Numerical Technologies

$0.00 /

+ (+0.00%)

Benzinga Biotech Small…

Benzinga Biotech Small Cap Virtual Conference will be held on March 24-25. Webcast Link

ShowHide Related Items >><<
YTEN Yield10 Bioscience
$14.20 /

-0.03 (-0.21%)

SRNE Sorrento Therapeutics
$8.96 /

-0.22 (-2.40%)

SKYE Skye Bioscience
$0.00 /

+ (+0.00%)

QLGN Qualigen Therapeutics
$2.93 /

+0.07 (+2.45%)

PRPH ProPhase Labs
$6.70 /

+ (+0.00%)

ONCS OncoSec
$5.46 /

-0.04 (-0.73%)

LIFE aTyr Pharma
$5.30 /

+0.37 (+7.51%)

KTRA Kintara Therapeutics
$1.98 /

+0.015 (+0.76%)

KRBP Kiromic BioPharma
$9.60 /

-0.2 (-2.04%)

HOTH Hoth Therapeutics
$2.30 /

-0.22 (-8.73%)

HEPA Hepion Pharmaceuticals
$2.08 /

-0.075 (-3.48%)

GOVX GeoVax Labs
$4.96 /

+0.06 (+1.22%)

GLSI Greenwich LifeSciences
$32.27 /

+1.78 (+5.84%)

ENVB Enveric Biosciences
$3.33 /

-0.01 (-0.30%)

DXR Daxor
$12.29 /

-0.55 (-4.28%)

CLVR Clever Leaves
$12.60 /

-0.11 (-0.87%)

BSGM BioSig Technologies
$4.53 /

+0.09 (+2.03%)

AXLA Axcella Health
$4.90 /

-0.03 (-0.61%)

ATNM Actinium Pharmaceuticals
$8.78 /

+0.31 (+3.66%)

AMYT Amryt Pharma
$13.61 /

+ (+0.00%)

ALIM Alimera Sciences
$9.71 /

+ (+0.00%)

ADTX Aditx Therapeutics
$3.17 /

+0.01 (+0.32%)

ACRX AcelRx
$1.70 /

-0.06 (-3.41%)

ACRX AcelRx
$1.70 /

-0.06 (-3.41%)

02/17/21 H.C. Wainwright
AcelRx warning letter is a 'nothingburger,' says H.C. Wainwright
07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
07/20/20
Fly Intel: Top five analyst downgrades
07/20/20 Credit Suisse
AcelRx downgraded to Underperform on 'mounting challenges' at Credit Suisse
ADTX Aditx Therapeutics
$3.17 /

+0.01 (+0.32%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Dawson James
Aditx Therapeutics initiated with a Buy at Dawson James
ALIM Alimera Sciences
$9.71 /

+ (+0.00%)

02/26/21 Alliance Global Partners
Alimera Sciences price target raised to $15 from $12 at Alliance Global Partners
01/07/21 Alliance Global Partners
Iluvien deal shows valuation disconnect at Alimera, says Alliance Global Partners
04/07/20 B. Riley
Alimera Sciences price target lowered to $15 from $24 at B. Riley FBR
AMYT Amryt Pharma
$13.61 /

+ (+0.00%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
ATNM Actinium Pharmaceuticals
$8.78 /

+0.31 (+3.66%)

12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
11/05/20 Alliance Global Partners
Actinium Pharmaceuticals initiated with a Buy at Alliance Global Partners
AXLA Axcella Health
$4.90 /

-0.03 (-0.61%)

03/22/21 Wedbush
Axcella Health price target lowered to $11 from $19 at Wedbush
03/18/21 Chardan
Axcella Health moving forward with two lead programs, says Chardan
11/18/20 Roth Capital
Axcella Health initiated with a Buy at Roth Capital
10/27/20
Fly Intel: Top five analyst initiations
BSGM BioSig Technologies
$4.53 /

+0.09 (+2.03%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Roth Capital
BioSig Technologies initiated with a Buy at Roth Capital
CLVR Clever Leaves
$12.60 /

-0.11 (-0.87%)

DXR Daxor
$12.29 /

-0.55 (-4.28%)

ENVB Enveric Biosciences
$3.33 /

-0.01 (-0.30%)

GLSI Greenwich LifeSciences
$32.27 /

+1.78 (+5.84%)

GOVX GeoVax Labs
$4.96 /

+0.06 (+1.22%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
HEPA Hepion Pharmaceuticals
$2.08 /

-0.075 (-3.48%)

12/01/20 Roth Capital
Hepion Pharmaceuticals price target lowered to $8 from $14 at Roth Capital
07/20/20 Roth Capital
Hepion Pharmaceuticals transferred with a Buy rating at Roth Capital
HOTH Hoth Therapeutics
$2.30 /

-0.22 (-8.73%)

KRBP Kiromic BioPharma
$9.60 /

-0.2 (-2.04%)

KTRA Kintara Therapeutics
$1.98 /

+0.015 (+0.76%)

09/14/20 Aegis
Kintara Therapeutics initiated with a Buy at Aegis
LIFE aTyr Pharma
$5.30 /

+0.37 (+7.51%)

03/16/21 Roth Capital
aTyr Pharma price target raised to $20 from $15 at Roth Capital
01/28/21 Roth Capital
Roth Capital says aTyr Pharma work on NRP2 'not to be ignored'
01/05/21 Roth Capital
Roth sees aTyr '1923 data 'supportive' of anti-inflammatory potential in COVID
08/17/20 H.C. Wainwright
aTyr Pharma upgraded to Buy from Neutral at H.C. Wainwright
SRNE Sorrento Therapeutics
$8.96 /

-0.22 (-2.40%)

01/29/21 B. Riley
Sorrento Therapeutics initiated with a Buy at B. Riley Securities
01/21/21 Alliance Global Partners
Sorrento Therapeutics initiated with a Buy at Alliance Global Partners
07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
SKYE Skye Bioscience
$0.00 /

+ (+0.00%)

QLGN Qualigen Therapeutics
$2.93 /

+0.07 (+2.45%)

08/25/20 Alliance Global Partners
Qualigen upgraded to Buy from Neutral at Alliance Global Partners
PRPH ProPhase Labs
$6.70 /

+ (+0.00%)

01/20/21 Dawson James
ProPhase Labs initiated with a Buy at Dawson James
YTEN Yield10 Bioscience
$14.20 /

-0.03 (-0.21%)

02/10/21 Maxim
Yield10 Bioscience price target raised to $24 from $12 at Maxim
02/09/21 Maxim
Yield10 Bioscience price target raised to $24 from $12 at Maxim
01/19/21 H.C. Wainwright
Yield10 Bioscience proof-of-concept validates pipeline, says H.C. Wainwright
09/10/20 H.C. Wainwright
Yield10 Bioscience initiated with a Buy at H.C. Wainwright
ONCS OncoSec
$5.46 /

-0.04 (-0.73%)

03/08/21
Fly Intel: Top five analyst initiations
03/08/21 BTIG
OncoSec initiated with a Buy at BTIG
07/27/20 Dawson James
OncoSec initiated with a Buy at Dawson James
07/14/20 Alliance Global Partners
OncoSec price target lowered to $6.50 from $9 at Alliance Global Partners
NMTC Numerical Technologies
$0.00 /

+ (+0.00%)

YTEN Yield10 Bioscience
$14.20 /

-0.03 (-0.21%)

QLGN Qualigen Therapeutics
$2.93 /

+0.07 (+2.45%)

LIFE aTyr Pharma
$5.30 /

+0.37 (+7.51%)

KTRA Kintara Therapeutics
$1.98 /

+0.015 (+0.76%)

AXLA Axcella Health
$4.90 /

-0.03 (-0.61%)

ALIM Alimera Sciences
$9.71 /

+ (+0.00%)

ADTX Aditx Therapeutics
$3.17 /

+0.01 (+0.32%)

ACRX AcelRx
$1.70 /

-0.06 (-3.41%)

  • 16
    Feb
  • 01
    Feb
  • 21
    Jan
  • 20
    Jan
  • 18
    Dec
  • 25
    Nov
  • 16
    Oct
  • 25
    Sep
  • 25
    Sep
  • 30
    Jun
  • 17
    Jun
  • 22
    May
  • 14
    May
  • 22
    Apr
GLSI Greenwich LifeSciences
$32.27 /

+1.78 (+5.84%)

YTEN Yield10 Bioscience
$14.20 /

-0.03 (-0.21%)

SRNE Sorrento Therapeutics
$8.96 /

-0.22 (-2.40%)

SKYE Skye Bioscience
$0.00 /

+ (+0.00%)

PRPH ProPhase Labs
$6.70 /

+ (+0.00%)

ONCS OncoSec
$5.46 /

-0.04 (-0.73%)

LIFE aTyr Pharma
$5.30 /

+0.37 (+7.51%)

KRBP Kiromic BioPharma
$9.60 /

-0.2 (-2.04%)

GOVX GeoVax Labs
$4.96 /

+0.06 (+1.22%)

GLSI Greenwich LifeSciences
$32.27 /

+1.78 (+5.84%)

ENVB Enveric Biosciences
$3.33 /

-0.01 (-0.30%)

CLVR Clever Leaves
$12.60 /

-0.11 (-0.87%)

AXLA Axcella Health
$4.90 /

-0.03 (-0.61%)

ATNM Actinium Pharmaceuticals
$8.78 /

+0.31 (+3.66%)

ACRX AcelRx
$1.70 /

-0.06 (-3.41%)

SRNE Sorrento Therapeutics
$8.96 /

-0.22 (-2.40%)

QLGN Qualigen Therapeutics
$2.93 /

+0.07 (+2.45%)

PRPH ProPhase Labs
$6.70 /

+ (+0.00%)

ONCS OncoSec
$5.46 /

-0.04 (-0.73%)

HEPA Hepion Pharmaceuticals
$2.08 /

-0.075 (-3.48%)

CLVR Clever Leaves
$12.60 /

-0.11 (-0.87%)

BSGM BioSig Technologies
$4.53 /

+0.09 (+2.03%)

ADTX Aditx Therapeutics
$3.17 /

+0.01 (+0.32%)

ACRX AcelRx
$1.70 /

-0.06 (-3.41%)

Conference/Events
Maxim Group to hold a virtual conference » 04:55
03/18/21
03/18
04:55
03/18/21
04:55
CNSP

CNS Pharmaceuticals

$2.85 /

+0.18 (+6.74%)

, KTRA

Kintara Therapeutics

$2.14 /

-0.02 (-0.93%)

, PSTV

Plus Therapeutics

$2.85 /

+0.08 (+2.89%)

, TCON

Tracon Pharmaceuticals

$9.30 /

+0.2 (+2.20%)

, MDNA

Medicenna Therapeutics

$4.01 /

-0.01 (-0.25%)

, INO

Inovio

$10.53 /

+0.07 (+0.67%)

, ONCR

Oncorus

$16.33 /

-0.485 (-2.88%)

, GOVX

GeoVax Labs

$5.73 /

+0.39 (+7.30%)

, HTBX

Heat Biologics

$8.66 /

+0.3 (+3.59%)

, SLS

Sellas Life Sciences

$11.67 /

+1.25 (+12.00%)

, PLSE

Pulse Biosciences

$25.60 /

-0.4 (-1.54%)

, SRTS

Sensus Healthcare

$4.39 /

-0.02 (-0.45%)

, VERO

Venus Concept

$2.77 /

+0.18 (+6.95%)

, SOLY

Soliton

$16.86 /

-0.67 (-3.82%)

, CLXPF

Cybin

$0.00 /

+ (+0.00%)

, MMED

Midas Medici

$0.00 /

+ (+0.00%)

, CHFS

CHF Solutions

$6.19 /

-1.15 (-15.67%)

, ECOR

electroCore

$2.19 /

+0.095 (+4.53%)

, BIOL

Biolase

$1.01 /

+0.0553 (+5.79%)

, AEMD

Aethlon Medical

$2.25 /

-0.06 (-2.60%)

, ZSAN

Zosano Pharma

$1.47 /

+0.14 (+10.53%)

, NLSP

NLS Pharmaceutics

$4.51 /

+0.15 (+3.44%)

, CYTH

Cyclo Therapeutics

$12.80 /

+0.41 (+3.31%)

, MNPR

Monopar Therapeutics

$7.38 /

-0.11 (-1.47%)

Inaugural Emerging Growth…

Inaugural Emerging Growth Virtual Conference 2021 will be held on March 17-19.

ShowHide Related Items >><<
ZSAN Zosano Pharma
$1.47 /

+0.14 (+10.53%)

TCON Tracon Pharmaceuticals
$9.30 /

+0.2 (+2.20%)

SRTS Sensus Healthcare
$4.39 /

-0.02 (-0.45%)

SOLY Soliton
$16.86 /

-0.67 (-3.82%)

SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

PSTV Plus Therapeutics
$2.85 /

+0.08 (+2.89%)

PLSE Pulse Biosciences
$25.60 /

-0.4 (-1.54%)

ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

NLSP NLS Pharmaceutics
$4.51 /

+0.15 (+3.44%)

MNPR Monopar Therapeutics
$7.38 /

-0.11 (-1.47%)

MDNA Medicenna Therapeutics
$4.01 /

-0.01 (-0.25%)

KTRA Kintara Therapeutics
$2.14 /

-0.02 (-0.93%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

GOVX GeoVax Labs
$5.73 /

+0.39 (+7.30%)

ECOR electroCore
$2.19 /

+0.095 (+4.53%)

CYTH Cyclo Therapeutics
$12.80 /

+0.41 (+3.31%)

CNSP CNS Pharmaceuticals
$2.85 /

+0.18 (+6.74%)

CHFS CHF Solutions
$6.19 /

-1.15 (-15.67%)

BIOL Biolase
$1.01 /

+0.0553 (+5.79%)

AEMD Aethlon Medical
$2.25 /

-0.06 (-2.60%)

CNSP CNS Pharmaceuticals
$2.85 /

+0.18 (+6.74%)

02/02/21 Brookline
CNS Pharmaceuticals initiated with a Buy at Brookline
12/28/20
Fly Intel: Top five analyst calls
12/28/20 Ladenburg
CNS Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/24/20 Ladenburg
CNS Pharmaceuticals initiated with a Buy at Ladenburg
KTRA Kintara Therapeutics
$2.14 /

-0.02 (-0.93%)

09/14/20 Aegis
Kintara Therapeutics initiated with a Buy at Aegis
PSTV Plus Therapeutics
$2.85 /

+0.08 (+2.89%)

02/11/21
Fly Intel: Top five analyst initiations
02/11/21 H.C. Wainwright
Plus Therapeutics initiated with a Buy at H.C. Wainwright
01/25/21 Ladenburg
Plus Therapeutics initiated with a Buy at Ladenburg
10/16/20
Fly Intel: Top five analyst initiations
TCON Tracon Pharmaceuticals
$9.30 /

+0.2 (+2.20%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Maxim
Tracon Pharmaceuticals initiated with a Buy at Maxim
12/04/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright
09/17/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright
MDNA Medicenna Therapeutics
$4.01 /

-0.01 (-0.25%)

12/17/20 Oppenheimer
Medicenna Therapeutics initiated with an Outperform at Oppenheimer
09/10/20 H.C. Wainwright
Medicenna Therapeutics initiated with a Buy at H.C. Wainwright
INO Inovio
$10.53 /

+0.07 (+0.67%)

03/02/21 Piper Sandler
Piper lowers Inovio target to $7 after 'decidedly negative' update
02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

03/16/21
Fly Intel: Top five analyst initiations
03/16/21 Maxim
Oncorus initiated with a Buy at Maxim
11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
GOVX GeoVax Labs
$5.73 /

+0.39 (+7.30%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

03/02/21 Cantor Fitzgerald
Heat Biologics initiated with an Overweight at Cantor Fitzgerald
02/09/21 Alliance Global Partners
Heat Biologics price target raised to $40 from $5 at Alliance Global Partners
12/24/20 B. Riley
Heat Biologics transferred with a Buy at B. Riley Securities
SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

12/21/20 Alliance Global Partners
Alliance Global Partners keeps Buy on Sellas following data from trials
PLSE Pulse Biosciences
$25.60 /

-0.4 (-1.54%)

03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
02/04/21 H.C. Wainwright
Pulse Biosciences price target raised to $46 from $40 at H.C. Wainwright
01/26/21 H.C. Wainwright
Pulse Biosciences price target raised to $40 from $16 at H.C. Wainwright
SRTS Sensus Healthcare
$4.39 /

-0.02 (-0.45%)

03/01/21 H.C. Wainwright
Sensus Healthcare price target raised to $6 from $4 at H.C. Wainwright
02/26/21 Northland
Northland upgrades Sensus Healthcare to Outperform after 'strong' Q4 report
02/26/21 Northland
Sensus Healthcare upgraded to Outperform from Market Perform at Northland
12/16/20 Northland
Sensus Healthcare downgraded to Market Perform on valuation at Northland
VERO Venus Concept
$2.77 /

+0.18 (+6.95%)

12/29/20 BTIG
Venus Concept flying under the radar, says BTIG
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
11/16/20 Oppenheimer
Venus Concept upgraded to Outperform with $4 target at Oppenheimer
SOLY Soliton
$16.86 /

-0.67 (-3.82%)

03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
07/15/20 Cantor Fitzgerald
Soliton initiated with an Overweight at Cantor Fitzgerald
CLXPF Cybin
$0.00 /

+ (+0.00%)

03/15/21 Canaccord
Cybin initiated with a Buy at Canaccord
01/14/21 Stifel
Cybin initiated with a Speculative Buy at Stifel
MMED Midas Medici
$0.00 /

+ (+0.00%)

CHFS CHF Solutions
$6.19 /

-1.15 (-15.67%)

10/21/20 Maxim
CHF Solutions price target lowered to $20 from $45 at Maxim
06/05/20 Maxim
CHF Solutions initiated with a Buy at Maxim
ECOR electroCore
$2.19 /

+0.095 (+4.53%)

10/22/20 Brookline
electroCore initiated with a Buy at Brookline
09/30/20
Fly Intel: Top five analyst initiationsNewPage
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
BIOL Biolase
$1.01 /

+0.0553 (+5.79%)

01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
10/14/20 Maxim
Biolase initiated with a Buy at Maxim
04/09/20
Biolase supplying ventilators 'highly encouraging,' says Dougherty
AEMD Aethlon Medical
$2.25 /

-0.06 (-2.60%)

01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Maxim
Aethlon Medical initiated with a Buy at Maxim
ZSAN Zosano Pharma
$1.47 /

+0.14 (+10.53%)

03/15/21 Maxim
Zosano Pharma price target raised to $2.50 from $1.50 at Maxim
10/22/20 BTIG
Zosano Pharma price target lowered to $2 from $7 at BTIG
10/02/20 H.C. Wainwright
Zosano Pharma price target lowered to $2.50 from $4 at H.C. Wainwright
09/14/20 BTIG
Satsuma setback a positive for Zosano Pharma, says BTIG
NLSP NLS Pharmaceutics
$4.51 /

+0.15 (+3.44%)

03/12/21 Brookline
NLS Pharmaceutics initiated with a Buy at Brookline
03/03/21 Maxim
NLS Pharmaceutics initiated with a Buy at Maxim
CYTH Cyclo Therapeutics
$12.80 /

+0.41 (+3.31%)

02/10/21 Maxim
Cyclo Therapeutics price target raised to $25 from $12 at Maxim
12/17/20 Maxim
Cyclo Therapeutics initiated with a Buy at Maxim
MNPR Monopar Therapeutics
$7.38 /

-0.11 (-1.47%)

01/28/21 Roth Capital
Monopar Therapeutics initiated with a Buy at Roth Capital
09/24/20 Maxim
Monopar Therapeutics initiated with a Buy at Maxim
06/16/20 JonesTrading
JonesTrading backs Buy on Monoper after NorthStar Medical collaboration
ZSAN Zosano Pharma
$1.47 /

+0.14 (+10.53%)

VERO Venus Concept
$2.77 /

+0.18 (+6.95%)

TCON Tracon Pharmaceuticals
$9.30 /

+0.2 (+2.20%)

SRTS Sensus Healthcare
$4.39 /

-0.02 (-0.45%)

SOLY Soliton
$16.86 /

-0.67 (-3.82%)

SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

PSTV Plus Therapeutics
$2.85 /

+0.08 (+2.89%)

ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

MNPR Monopar Therapeutics
$7.38 /

-0.11 (-1.47%)

MDNA Medicenna Therapeutics
$4.01 /

-0.01 (-0.25%)

KTRA Kintara Therapeutics
$2.14 /

-0.02 (-0.93%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

ECOR electroCore
$2.19 /

+0.095 (+4.53%)

CHFS CHF Solutions
$6.19 /

-1.15 (-15.67%)

BIOL Biolase
$1.01 /

+0.0553 (+5.79%)

AEMD Aethlon Medical
$2.25 /

-0.06 (-2.60%)

  • 17
    Mar
  • 12
    Feb
  • 29
    Jan
  • 21
    Jan
  • 23
    Dec
  • 22
    Dec
  • 02
    Oct
  • 25
    Sep
  • 01
    Sep
  • 26
    Jun
SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

ZSAN Zosano Pharma
$1.47 /

+0.14 (+10.53%)

VERO Venus Concept
$2.77 /

+0.18 (+6.95%)

ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

NLSP NLS Pharmaceutics
$4.51 /

+0.15 (+3.44%)

MDNA Medicenna Therapeutics
$4.01 /

-0.01 (-0.25%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

GOVX GeoVax Labs
$5.73 /

+0.39 (+7.30%)

TCON Tracon Pharmaceuticals
$9.30 /

+0.2 (+2.20%)

SLS Sellas Life Sciences
$11.67 /

+1.25 (+12.00%)

ONCR Oncorus
$16.33 /

-0.485 (-2.88%)

INO Inovio
$10.53 /

+0.07 (+0.67%)

HTBX Heat Biologics
$8.66 /

+0.3 (+3.59%)

Conference/Events
Maxim Group to hold a virtual conference » 09:48
03/17/21
03/17
09:48
03/17/21
09:48
CNSP

CNS Pharmaceuticals

$2.65 /

-0.02 (-0.75%)

, KTRA

Kintara Therapeutics

$2.08 /

-0.08 (-3.70%)

, PSTV

Plus Therapeutics

$2.75 /

-0.02 (-0.72%)

, TCON

Tracon Pharmaceuticals

$8.80 /

-0.3 (-3.30%)

, MDNA

Medicenna Therapeutics

$4.00 /

-0.02 (-0.50%)

, INO

Inovio

$10.33 /

-0.13 (-1.24%)

, ONCR

Oncorus

$16.50 /

-0.315 (-1.87%)

, GOVX

GeoVax Labs

$5.40 /

+0.06 (+1.12%)

, HTBX

Heat Biologics

$8.12 /

-0.24 (-2.87%)

, SLS

Sellas Life Sciences

$10.42 /

+ (+0.00%)

, PLSE

Pulse Biosciences

$26.20 /

+0.2 (+0.77%)

, SRTS

Sensus Healthcare

$4.40 /

-0.01 (-0.23%)

, VERO

Venus Concept

$2.43 /

-0.16 (-6.18%)

, SOLY

Soliton

$16.80 /

-0.73 (-4.16%)

, CLXPF

Cybin

$0.00 /

+ (+0.00%)

, MMED

Midas Medici

$0.00 /

+ (+0.00%)

, CHFS

CHF Solutions

$5.87 /

-1.47 (-20.03%)

, ECOR

electroCore

$2.07 /

-0.025 (-1.19%)

, BIOL

Biolase

$0.90 /

-0.0547 (-5.73%)

, AEMD

Aethlon Medical

$2.22 /

-0.09 (-3.90%)

, ZSAN

Zosano Pharma

$1.38 /

+0.05 (+3.76%)

, NLSP

NLS Pharmaceutics

$4.32 /

-0.04 (-0.92%)

, CYTH

Cyclo Therapeutics

$11.56 /

-0.83 (-6.70%)

, MNPR

Monopar Therapeutics

$7.40 /

-0.09 (-1.20%)

Inaugural Emerging Growth…

Inaugural Emerging Growth Virtual Conference 2021 will be held on March 17-19.

ShowHide Related Items >><<
ZSAN Zosano Pharma
$1.38 /

+0.05 (+3.76%)

TCON Tracon Pharmaceuticals
$8.80 /

-0.3 (-3.30%)

SRTS Sensus Healthcare
$4.40 /

-0.01 (-0.23%)

SOLY Soliton
$16.80 /

-0.73 (-4.16%)

SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

PSTV Plus Therapeutics
$2.75 /

-0.02 (-0.72%)

PLSE Pulse Biosciences
$26.20 /

+0.2 (+0.77%)

ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

NLSP NLS Pharmaceutics
$4.32 /

-0.04 (-0.92%)

MNPR Monopar Therapeutics
$7.40 /

-0.09 (-1.20%)

MDNA Medicenna Therapeutics
$4.00 /

-0.02 (-0.50%)

KTRA Kintara Therapeutics
$2.08 /

-0.08 (-3.70%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

GOVX GeoVax Labs
$5.40 /

+0.06 (+1.12%)

ECOR electroCore
$2.07 /

-0.025 (-1.19%)

CYTH Cyclo Therapeutics
$11.56 /

-0.83 (-6.70%)

CNSP CNS Pharmaceuticals
$2.65 /

-0.02 (-0.75%)

CHFS CHF Solutions
$5.87 /

-1.47 (-20.03%)

BIOL Biolase
$0.90 /

-0.0547 (-5.73%)

AEMD Aethlon Medical
$2.22 /

-0.09 (-3.90%)

CNSP CNS Pharmaceuticals
$2.65 /

-0.02 (-0.75%)

02/02/21 Brookline
CNS Pharmaceuticals initiated with a Buy at Brookline
12/28/20
Fly Intel: Top five analyst calls
12/28/20 Ladenburg
CNS Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/24/20 Ladenburg
CNS Pharmaceuticals initiated with a Buy at Ladenburg
KTRA Kintara Therapeutics
$2.08 /

-0.08 (-3.70%)

09/14/20 Aegis
Kintara Therapeutics initiated with a Buy at Aegis
PSTV Plus Therapeutics
$2.75 /

-0.02 (-0.72%)

02/11/21
Fly Intel: Top five analyst initiations
02/11/21 H.C. Wainwright
Plus Therapeutics initiated with a Buy at H.C. Wainwright
01/25/21 Ladenburg
Plus Therapeutics initiated with a Buy at Ladenburg
10/16/20
Fly Intel: Top five analyst initiations
TCON Tracon Pharmaceuticals
$8.80 /

-0.3 (-3.30%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Maxim
Tracon Pharmaceuticals initiated with a Buy at Maxim
12/04/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright
09/17/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright
MDNA Medicenna Therapeutics
$4.00 /

-0.02 (-0.50%)

12/17/20 Oppenheimer
Medicenna Therapeutics initiated with an Outperform at Oppenheimer
09/10/20 H.C. Wainwright
Medicenna Therapeutics initiated with a Buy at H.C. Wainwright
INO Inovio
$10.33 /

-0.13 (-1.24%)

03/02/21 Piper Sandler
Piper lowers Inovio target to $7 after 'decidedly negative' update
02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

03/16/21
Fly Intel: Top five analyst initiations
03/16/21 Maxim
Oncorus initiated with a Buy at Maxim
11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
GOVX GeoVax Labs
$5.40 /

+0.06 (+1.12%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

03/02/21 Cantor Fitzgerald
Heat Biologics initiated with an Overweight at Cantor Fitzgerald
02/09/21 Alliance Global Partners
Heat Biologics price target raised to $40 from $5 at Alliance Global Partners
12/24/20 B. Riley
Heat Biologics transferred with a Buy at B. Riley Securities
SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

12/21/20 Alliance Global Partners
Alliance Global Partners keeps Buy on Sellas following data from trials
PLSE Pulse Biosciences
$26.20 /

+0.2 (+0.77%)

03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
02/04/21 H.C. Wainwright
Pulse Biosciences price target raised to $46 from $40 at H.C. Wainwright
01/26/21 H.C. Wainwright
Pulse Biosciences price target raised to $40 from $16 at H.C. Wainwright
SRTS Sensus Healthcare
$4.40 /

-0.01 (-0.23%)

03/01/21 H.C. Wainwright
Sensus Healthcare price target raised to $6 from $4 at H.C. Wainwright
02/26/21 Northland
Northland upgrades Sensus Healthcare to Outperform after 'strong' Q4 report
02/26/21 Northland
Sensus Healthcare upgraded to Outperform from Market Perform at Northland
12/16/20 Northland
Sensus Healthcare downgraded to Market Perform on valuation at Northland
VERO Venus Concept
$2.43 /

-0.16 (-6.18%)

12/29/20 BTIG
Venus Concept flying under the radar, says BTIG
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
11/16/20 Oppenheimer
Venus Concept upgraded to Outperform with $4 target at Oppenheimer
SOLY Soliton
$16.80 /

-0.73 (-4.16%)

03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
07/15/20 Cantor Fitzgerald
Soliton initiated with an Overweight at Cantor Fitzgerald
CLXPF Cybin
$0.00 /

+ (+0.00%)

03/15/21 Canaccord
Cybin initiated with a Buy at Canaccord
01/14/21 Stifel
Cybin initiated with a Speculative Buy at Stifel
MMED Midas Medici
$0.00 /

+ (+0.00%)

CHFS CHF Solutions
$5.87 /

-1.47 (-20.03%)

10/21/20 Maxim
CHF Solutions price target lowered to $20 from $45 at Maxim
06/05/20 Maxim
CHF Solutions initiated with a Buy at Maxim
ECOR electroCore
$2.07 /

-0.025 (-1.19%)

10/22/20 Brookline
electroCore initiated with a Buy at Brookline
09/30/20
Fly Intel: Top five analyst initiationsNewPage
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
09/30/20 Maxim
electroCore initiated with a Buy at Maxim
BIOL Biolase
$0.90 /

-0.0547 (-5.73%)

01/26/21 Maxim
Biolase price target raised to $2 at Maxim on 'strong' preliminary Q4 revenue
10/14/20 Maxim
Biolase initiated with a Buy at Maxim
04/09/20
Biolase supplying ventilators 'highly encouraging,' says Dougherty
AEMD Aethlon Medical
$2.22 /

-0.09 (-3.90%)

01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Maxim
Aethlon Medical initiated with a Buy at Maxim
ZSAN Zosano Pharma
$1.38 /

+0.05 (+3.76%)

03/15/21 Maxim
Zosano Pharma price target raised to $2.50 from $1.50 at Maxim
10/22/20 BTIG
Zosano Pharma price target lowered to $2 from $7 at BTIG
10/02/20 H.C. Wainwright
Zosano Pharma price target lowered to $2.50 from $4 at H.C. Wainwright
09/14/20 BTIG
Satsuma setback a positive for Zosano Pharma, says BTIG
NLSP NLS Pharmaceutics
$4.32 /

-0.04 (-0.92%)

03/12/21 Brookline
NLS Pharmaceutics initiated with a Buy at Brookline
03/03/21 Maxim
NLS Pharmaceutics initiated with a Buy at Maxim
CYTH Cyclo Therapeutics
$11.56 /

-0.83 (-6.70%)

02/10/21 Maxim
Cyclo Therapeutics price target raised to $25 from $12 at Maxim
12/17/20 Maxim
Cyclo Therapeutics initiated with a Buy at Maxim
MNPR Monopar Therapeutics
$7.40 /

-0.09 (-1.20%)

01/28/21 Roth Capital
Monopar Therapeutics initiated with a Buy at Roth Capital
09/24/20 Maxim
Monopar Therapeutics initiated with a Buy at Maxim
06/16/20 JonesTrading
JonesTrading backs Buy on Monoper after NorthStar Medical collaboration
ZSAN Zosano Pharma
$1.38 /

+0.05 (+3.76%)

VERO Venus Concept
$2.43 /

-0.16 (-6.18%)

TCON Tracon Pharmaceuticals
$8.80 /

-0.3 (-3.30%)

SRTS Sensus Healthcare
$4.40 /

-0.01 (-0.23%)

SOLY Soliton
$16.80 /

-0.73 (-4.16%)

SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

PSTV Plus Therapeutics
$2.75 /

-0.02 (-0.72%)

ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

MNPR Monopar Therapeutics
$7.40 /

-0.09 (-1.20%)

MDNA Medicenna Therapeutics
$4.00 /

-0.02 (-0.50%)

KTRA Kintara Therapeutics
$2.08 /

-0.08 (-3.70%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

ECOR electroCore
$2.07 /

-0.025 (-1.19%)

CHFS CHF Solutions
$5.87 /

-1.47 (-20.03%)

BIOL Biolase
$0.90 /

-0.0547 (-5.73%)

AEMD Aethlon Medical
$2.22 /

-0.09 (-3.90%)

  • 17
    Mar
  • 12
    Feb
  • 29
    Jan
  • 21
    Jan
  • 23
    Dec
  • 22
    Dec
  • 02
    Oct
  • 25
    Sep
  • 01
    Sep
  • 26
    Jun
SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

ZSAN Zosano Pharma
$1.38 /

+0.05 (+3.76%)

VERO Venus Concept
$2.43 /

-0.16 (-6.18%)

ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

NLSP NLS Pharmaceutics
$4.32 /

-0.04 (-0.92%)

MDNA Medicenna Therapeutics
$4.00 /

-0.02 (-0.50%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

GOVX GeoVax Labs
$5.40 /

+0.06 (+1.12%)

TCON Tracon Pharmaceuticals
$8.80 /

-0.3 (-3.30%)

SLS Sellas Life Sciences
$10.42 /

+ (+0.00%)

ONCR Oncorus
$16.50 /

-0.315 (-1.87%)

INO Inovio
$10.33 /

-0.13 (-1.24%)

HTBX Heat Biologics
$8.12 /

-0.24 (-2.87%)

Hot Stocks
GeoVax Labs files two patent applications related to COVID-19 vaccines, cancer » 09:58
03/04/21
03/04
09:58
03/04/21
09:58
GOVX

GeoVax Labs

$4.70 /

-0.06 (-1.26%)

GeoVax Labs announced the…

GeoVax Labs announced the filing of two additional patent applications important to the company's key focus on vaccines against COVID-19 and cancer immunotherapies. The company has filed an International Patent Application under the Patent Cooperation Treaty to protect its proprietary COVID-19 vaccines based on its platform modified vaccinia Ankara viral vector technology. Unlike certain competitor vaccines that target only the COVID-19 spike protein, GeoVax's vaccines are designed to provoke a response to multiple COVID-19 antigens, which are differentiated from competitive vaccines in that they may be less susceptible to viral mutations in the spike protein region that have emerged as problematic in multiple regions of the world. The company's vaccines are intended to be used as a primary vaccine or to boost COVID-19 vaccines from other companies as part of vaccination strategies to provide immunity to a range of SARS-CoV-2 variants. GeoVax also filed a U.S. patent application as part of its immunotherapy program, which covers updates in its innovative MVA viral vector technology to amplify an immune response to a cancer antigen in a patient via vaccination. Cancer vaccination is the subject of growing interest as a means to boost the body's innate defense to cancer.

ShowHide Related Items >><<
GOVX GeoVax Labs
$4.70 /

-0.06 (-1.26%)

GOVX GeoVax Labs
$4.70 /

-0.06 (-1.26%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
  • 25
    Sep
GOVX GeoVax Labs
$4.70 /

-0.06 (-1.26%)

Syndicate
GeoVax Labs raises $9M in a bought deal offering » 06:35
02/09/21
02/09
06:35
02/09/21
06:35
GOVX

GeoVax Labs

$7.47 /

+2.02 (+37.06%)

GeoVax announced that it…

GeoVax announced that it has entered into an underwriting agreement with Maxim Group LLC under which the underwriter has agreed to purchase, on a firm commitment basis, 1,440,000 shares of common stock of the Company, at a price to the public of $6.25 per share less underwriting discounts and commissions. Maxim Group LLC is acting as sole book-running manager for the offering.

ShowHide Related Items >><<
GOVX GeoVax Labs
$7.47 /

+2.02 (+37.06%)

GOVX GeoVax Labs
$7.47 /

+2.02 (+37.06%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
  • 25
    Sep
GOVX GeoVax Labs
$7.47 /

+2.02 (+37.06%)

Over a quarter ago
Syndicate
GeoVax Labs files $101.45M mixed securities shelf  17:03
01/26/21
01/26
17:03
01/26/21
17:03
GOVX

GeoVax Labs

$5.94 /

+0.84 (+16.47%)

 
ShowHide Related Items >><<
GOVX GeoVax Labs
$5.94 /

+0.84 (+16.47%)

GOVX GeoVax Labs
$5.94 /

+0.84 (+16.47%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
  • 25
    Sep
GOVX GeoVax Labs
$5.94 /

+0.84 (+16.47%)

Hot Stocks
GeoVax Labs awarded NIH grant to advance vaccine development » 09:40
01/11/21
01/11
09:40
01/11/21
09:40
GOVX

GeoVax Labs

$3.35 /

+0.02 (+0.60%)

GeoVax Labs announced…

GeoVax Labs announced that the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded the Company a Small Business Innovative Research grant in support of its development of a vaccine against SARS-CoV-2, the virus that causes COVID-19. The Phase 1 grant, titled, "Preclinical Development of GV-MVA-VLP Vaccines Against COVID-19," will support the ongoing design, construction and preclinical testing of GeoVax's vaccine candidates in preparation for human clinical trials. The efficacy testing will be performed in collaboration with the University of Texas Medical Branch.

ShowHide Related Items >><<
GOVX GeoVax Labs
$3.35 /

+0.02 (+0.60%)

GOVX GeoVax Labs
$3.35 /

+0.02 (+0.60%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
  • 25
    Sep
GOVX GeoVax Labs
$3.35 /

+0.02 (+0.60%)

Hot Stocks
GeoVax Labs announces license agreement with NIH to support vaccine development » 09:02
11/30/20
11/30
09:02
11/30/20
09:02
GOVX

GeoVax Labs

$2.65 /

+0.03 (+1.15%)

GeoVax Labs announced the…

GeoVax Labs announced the signing of a Patent and Biological Materials License Agreement with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, in support of GeoVax's non-clinical development of vaccines against numerous pathogens. The License Agreement provides GeoVax with access to certain materials and patent rights owned by agencies of the Department of Health and Human Services for use in combination with the Company's proprietary technology for the creation of preventive and/or therapeutic vaccines against Ebola-Zaire, Ebola-Sudan, Lassa virus, Marburg virus, Zika virus and malaria. The agreement also extends to the Company's research and development efforts in certain oncology areas. The agreement provides GeoVax with nonexclusive rights for the nonclinical development and manufacturing of its vaccine and immunotherapy candidates using HHS patents and materials. Financial terms of the License Agreement were not disclosed.

ShowHide Related Items >><<
GOVX GeoVax Labs
$2.65 /

+0.03 (+1.15%)

GOVX GeoVax Labs
$2.65 /

+0.03 (+1.15%)

11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
11/19/20 Maxim
GeoVax Labs initiated with a Buy at Maxim
  • 25
    Sep
GOVX GeoVax Labs
$2.65 /

+0.03 (+1.15%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.